Efficacy and safety of dapagliflozin for treating heart failure in China: A meta-analysis

Wanshi Wu; Shang Yao; Qing Xu; Hui Cheng; Qing Jiang

doi:10.36721/PJPS.2023.36.6.REG.1687-1693.1

original articles

Efficacy and safety of dapagliflozin for treating heart failure in China: A meta-analysis

Wanshi Wu, Shang Yao, Qing Xu, Hui Cheng, Qing Jiang

Vol. 36

Issue 6

Pages 1687-1693

Published 01 Nov 2023

DOI: 10.36721/PJPS.2023.36.6.REG.1687-1693.1

Authors Abstract Related

Authors & Affiliations

Wanshi Wu

Shang Yao

Qing Xu

Hui Cheng

Qing Jiang

Abstract

This study assesses the efficacy and safety of dapagliflozin in Chinese patients with heart failure

Keywords

Dapagliflozin

heart failure

efficacy

safety

China

Metrics

PlumX Metrics

original articles

Efficacy and safety of dapagliflozin for treating heart failure in China: A meta-analysis

Wanshi Wu, Shang Yao, Qing Xu, Hui Cheng, Qing Jiang

Vol. 36

Issue 6

Pages 1687-1693

Published 01 Nov 2023

DOI: 10.36721/PJPS.2023.36.6.REG.1687-1693.1

Authors Abstract Related

Authors & Affiliations

Wanshi Wu

Shang Yao

Qing Xu

Hui Cheng

Qing Jiang

Abstract

This study assesses the efficacy and safety of dapagliflozin in Chinese patients with heart failure

Keywords

Dapagliflozin

heart failure

efficacy

safety

China

Metrics

PlumX Metrics

Efficacy and safety of dapagliflozin for treating heart failure in China: A meta-analysis

Authors & Affiliations

Abstract

Keywords

Metrics

Indexed & Abstracted in Leading Databases

Efficacy and safety of dapagliflozin for treating heart failure in China: A meta-analysis

Authors & Affiliations

Abstract

Keywords

Metrics